Clinical Presentation & Protocol
Patient Usually Complains Of
Patient presents with progressive fatigue, exercise intolerance, and dyspnea on exertion. History significant for CKD (Stage [X]). Reports worsening pallor, dizziness, and decreased cognitive focus. No overt signs of acute hemorrhage or melena. Symptoms correlate with declining hemoglobin levels and reduced eGFR.
Clinical Examination Findings
General appearance: Pale conjunctiva and mucous membranes. Skin: Pallor noted, no petechiae or ecchymosis. Vitals: Tachycardia may be present during exertion. Neurological: Alert and oriented, no focal deficits.
Treatment Protocol
Initiate ESA (Erythropoiesis-Stimulating Agent) therapy per protocol, targeting Hb [10-11.5 g/dL]. Assess iron stores (TSAT > 30%, Ferritin > 500 ng/mL). Administer IV iron supplementation as indicated. Monitor blood pressure closely due to ESA-associated hypertension risk.